Basic Information
ERC Belgium S.A. is a clinical-stage emerging biopharmaceutical company developing a safe and effective method for treating cancer, particularly brain cancer. ERC has established a network of leading neuro-oncologists across many countries to advance its immunotherapy through clinical development and market entry. ERC has developed a unique advanced cell-based immunotherapy invented by Pr. Apostolos Stathopoulos for treating patients with brain cancer. This therapeutic vaccine, known as ERC1671 (Gliovac™), specifically targets high-grade gliomas.